Phibro Animal Health (NASDAQ:PAHC) Issues FY 2022 Earnings Guidance

Phibro Animal Health (NASDAQ:PAHCGet Rating) updated its FY 2022 earnings guidance on Monday. The company provided earnings per share guidance of $1.30-$1.39 for the period, compared to the consensus earnings per share estimate of $1.36. The company issued revenue guidance of $930.00 million-$950.00 million, compared to the consensus revenue estimate of $907.54 million.

NASDAQ:PAHC traded down $0.39 during mid-day trading on Monday, reaching $18.34. The stock had a trading volume of 4,479 shares, compared to its average volume of 97,113. The stock has a market cap of $742.84 million, a P/E ratio of 12.92 and a beta of 0.56. The business’s 50 day moving average is $19.71 and its 200 day moving average is $20.41. The company has a debt-to-equity ratio of 1.50, a current ratio of 2.92 and a quick ratio of 1.67. Phibro Animal Health has a fifty-two week low of $17.28 and a fifty-two week high of $31.00.

Phibro Animal Health (NASDAQ:PAHCGet Rating) last posted its earnings results on Wednesday, May 4th. The company reported $0.33 EPS for the quarter, missing the consensus estimate of $0.35 by ($0.02). Phibro Animal Health had a return on equity of 21.06% and a net margin of 6.48%. During the same quarter in the prior year, the company earned $0.34 earnings per share. Equities analysts expect that Phibro Animal Health will post 1.36 EPS for the current year.

The business also recently announced a quarterly dividend, which will be paid on Wednesday, June 22nd. Shareholders of record on Wednesday, June 1st will be issued a dividend of $0.12 per share. The ex-dividend date of this dividend is Tuesday, May 31st. This represents a $0.48 annualized dividend and a yield of 2.62%. Phibro Animal Health’s dividend payout ratio (DPR) is currently 33.10%.

Several equities research analysts recently weighed in on PAHC shares. Barclays upgraded Phibro Animal Health from an underweight rating to an equal weight rating and set a $23.00 target price for the company in a report on Monday, January 10th. StockNews.com cut shares of Phibro Animal Health from a strong-buy rating to a buy rating in a research note on Thursday.

A number of institutional investors and hedge funds have recently added to or reduced their stakes in the business. Charles Schwab Investment Management Inc. increased its stake in Phibro Animal Health by 28.5% during the fourth quarter. Charles Schwab Investment Management Inc. now owns 195,730 shares of the company’s stock valued at $3,997,000 after acquiring an additional 43,358 shares during the period. Invesco Ltd. boosted its stake in Phibro Animal Health by 2.0% during the fourth quarter. Invesco Ltd. now owns 169,489 shares of the company’s stock worth $3,461,000 after buying an additional 3,353 shares in the last quarter. Parametric Portfolio Associates LLC increased its holdings in Phibro Animal Health by 4.5% in the 4th quarter. Parametric Portfolio Associates LLC now owns 102,889 shares of the company’s stock valued at $2,101,000 after buying an additional 4,418 shares during the period. D. E. Shaw & Co. Inc. raised its stake in shares of Phibro Animal Health by 12.3% in the 4th quarter. D. E. Shaw & Co. Inc. now owns 72,450 shares of the company’s stock valued at $1,479,000 after buying an additional 7,952 shares in the last quarter. Finally, Legal & General Group Plc lifted its holdings in shares of Phibro Animal Health by 3.3% during the 4th quarter. Legal & General Group Plc now owns 50,859 shares of the company’s stock worth $1,039,000 after acquiring an additional 1,637 shares during the period. 50.06% of the stock is currently owned by hedge funds and other institutional investors.

Phibro Animal Health Company Profile (Get Rating)

Phibro Animal Health Corporation develops, manufactures, and supplies a range of animal health and mineral nutrition products for livestock primarily in the United States. It operates through three segments: Animal Health, Mineral Nutrition, and Performance Products. The company develops, manufactures, and markets products for a range of food animals, including poultry, swine, beef and dairy cattle, and aquaculture.

Featured Stories

Receive News & Ratings for Phibro Animal Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Phibro Animal Health and related companies with MarketBeat.com's FREE daily email newsletter.